mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.3 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.3 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.3 |